Special Issue "Marine Natural Products for Cardiovascular Disease"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 June 2018)
Prof. Dr. Lindsay Brown
School of Health and Wellbeing, University of Southern Queensland, Toowoomba, Australia
Website | E-Mail
Phone: +61 7 4631 1319
Interests: functional foods; chronic inflammatory diseases; obesity; diabetes; heart disease; liver disease; arthritis; kidney failure; cardiovascular and endocrine pharmacology; animal models; metabolic syndrome
The marine environment is a rich source of bioactive compounds, but only few of these have been fully characterised for their therapeutic potential. Chronic cardiovascular disease remains the major cause of premature death or chronic ill health. One way to address these problems could be the development of effective treatments using evidenced-based studies on marine bioactive compounds. Marine products including algae, pigments, minerals and fibre are potentially both sustainable and commercially viable and thus represents a realistic alternative for the prevention and treatment of chronic cardiovascular disease. As many of the marine products are functional foods, these can target the problem of food security by serving as the sources of macro- and micro-nutrients.
This Special Issue will highlight the updates on research that identifies cardiovascular benefits of the marine products and recognise extracted products for the effects on cardiovascular disease and co-morbidities using both pre-clinical and clinical settings.
Prof. Lindsay Brown
Dr. Sunil K Panchal
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.